A major obstacle to stem-cell gene therapy rests in the inability to delive
r a gene into a therapeutically relevant fraction of stem cells'. One way t
o circumvent this obstacle is to use selection. Vectors containing two link
ed genes serve as the basis for selection. with one gene encoding a selecta
ble product and the other, a therapeutic protein. Applying selection in viv
o has the potential to bring a minor population of genetically corrected ce
lls into the therapeutic range. But strategies for achieving in vivo select
ion have traditionally relied on genes that confer resistance to cytotoxic
drugs(2,3) and are encumbered by toxicity. Here we describe a new system fo
r in vivo selection that uses a 'cell-growth switch'. allowing a minor popu
lation of genetically modified cells to be inducibly amplified, thereby ave
rting the risks associated with cytotoxic drugs. This system provides a gen
eral platform for conditionally expanding genetically modified cell populat
ions in vivo. and may have widespread applications in gene and cell therapy
.